Results 221 to 230 of about 15,464,746 (377)

BMP antagonist CHRDL2 enhances the cancer stem‐cell phenotype and increases chemotherapy resistance in colorectal cancer

Molecular Oncology, EarlyView.
Overexpression of CHRDL2 in colon cancer cells makes them more stem‐like and resistant to chemo‐ and radiotherapy. CHRDL2‐high cells have upregulation of the WNT pathway, genes involved in the DNA damage response (DDR) pathway and epithelial‐to‐mesenchymal transition (EMT). This leads to quicker repair of damaged DNA and more cell migration.
Eloise Clarkson, Annabelle Lewis
wiley   +1 more source

An AIoT enabled system for optimizing data retrieval in the intensive care unit evaluated in a randomized crossover pilot trial. [PDF]

Sci Rep
Tseng HY, Feng WS, Chen CL, Lin JY, Chou CY, Chen CH, Teng CK, Lin YC, Shen YC, Fu YC, Hsu WH, Tu CY, Chen WC, Cho DY.   +13 more
europepmc   +1 more source

A COMPARISON OF THE METHODS FOR THE COLLECTION OF BLOOD TO BE USED IN THE DETERMINATION OF GASES

, 1934
Joseph M. Looney, Hazel M. Childs
openalex   +1 more source

EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines

Molecular Oncology, EarlyView.
The Parsortix® system was tested for CTC enrichment using pancreatic cancer cell lines with different EMT phenotypes. Spike‐in experiments showed lower recovery of mesenchymal‐like cells. This was confirmed with an EMT‐inducible breast cancer cell line.
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes   +8 more
wiley   +1 more source

Developing a core collection for the conservation of Theobroma cacao's genetic diversity. [PDF]

BMC Genomics
Todd ET, Arigoni F, Holzwarth JA, Bellanger L, Descombes P, Beche E, Lass T, Guiltinan MJ, Maximova SN, Leandro M, Mérot V, Lepelley M, Fillodeau A.   +12 more
europepmc   +1 more source

Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer

Molecular Oncology, EarlyView.
Analysis of treatment‐naïve high‐grade serous ovarian carcinoma (HGSOC) and control tissues for ERVs, LINE‐1 (L1), inflammation, and immune checkpoints identified five clusters with diverse patient recurrence‐free survivals. An inflammation score was calculated and correlated with retroelement expression, where one novel cluster (Triple‐I) with high ...
Laura Glossner, Markus Eckstein, Christoph Mark, Matthias W. Beckmann, Arndt Hartmann, Pamela L. Strissel, Reiner Strick   +6 more
wiley   +1 more source

The dragonflies in the collection of Sapienza University of Rome. [PDF]

Biodivers Data J
Tamagnini D, Cerretti P, De Leo N, Chimenti C.   +3 more
europepmc   +1 more source

XLV.—On new Lamiide Coleoptera in the British-Museum collection [PDF]

, 1889
C.J. Gahan
openalex   +1 more source

Methods of data collection in qualitative research: interviews and focus groups

BDJ, 2008
Paul Gill, K. Stewart, E. Treasure, B. Chadwick   +3 more
semanticscholar   +1 more source

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

Molecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva, Bernardo Orr, Ana Azeredo, Andreia Brandão, Manuel R. Teixeira, Paula Paulo   +5 more
wiley   +1 more source